Biodyne, Inc. – Trademark Portfolio
Entity Type: 03
Biodyne, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include BIODYNE, ENVIRONOC, ENVIROBREW, BIODYNE USA, and BIODYNE WORLD. The owner is based in El Cajon, CA.
1466 Pioneer Way
Suite 13
El Cajon, CA 92020
Showing of trademarks Trademarks
Trademark Classifications
Biodyne, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Biodyne, Inc. have?
Biodyne, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned, 4 cancelled.
What trademark classes does Biodyne, Inc. file in?
Biodyne, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Biodyne, Inc.'s most well-known trademarks?
Biodyne, Inc.'s registered trademark portfolio includes well-known marks such as BIODYNE, ENVIRONOC, ENVIROBREW, BIODYNE USA, and BIODYNE WORLD. These are among 9 currently registered trademarks in the portfolio.
What is Biodyne, Inc.'s trademark registration success rate?
Biodyne, Inc. has a 60% trademark registration rate, with 9 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.